ENFUSION INC - CLASS A (ENFN)

US2928121043 - Common Stock

10.58  +0.06 (+0.57%)

After market: 10.58 0 (0%)

Fundamental Rating

6

Taking everything into account, ENFN scores 6 out of 10 in our fundamental rating. ENFN was compared to 280 industry peers in the Software industry. ENFN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ENFN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!



4

1. Profitability

1.1 Basic Checks

In the past year ENFN was profitable.
In the past year ENFN had a positive cash flow from operations.
In multiple years ENFN reported negative net income over the last 5 years.
Of the past 5 years ENFN 4 years had a positive operating cash flow.

1.2 Ratios

ENFN has a better Return On Assets (2.48%) than 68.46% of its industry peers.
ENFN has a Return On Equity of 4.78%. This is in the better half of the industry: ENFN outperforms 72.40% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.85%, ENFN is in the better half of the industry, outperforming 73.48% of the companies in the same industry.
Industry RankSector Rank
ROA 2.48%
ROE 4.78%
ROIC 4.85%
ROA(3y)-59.38%
ROA(5y)-22.58%
ROE(3y)-113.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ENFN has a Profit Margin of 1.71%. This is in the better half of the industry: ENFN outperforms 65.59% of its industry peers.
ENFN's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 3.44%, ENFN is doing good in the industry, outperforming 68.10% of the companies in the same industry.
ENFN's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 67.16%, ENFN perfoms like the industry average, outperforming 49.10% of the companies in the same industry.
In the last couple of years the Gross Margin of ENFN has declined.
Industry RankSector Rank
OM 3.44%
PM (TTM) 1.71%
GM 67.16%
OM growth 3Y-3.69%
OM growth 5YN/A
PM growth 3Y-11.03%
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

ENFN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ENFN has more shares outstanding than it did 1 year ago.
There is no outstanding debt for ENFN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 12.95 indicates that ENFN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.95, ENFN belongs to the top of the industry, outperforming 86.02% of the companies in the same industry.
ENFN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.95
ROIC/WACC0.41
WACC11.83%

2.3 Liquidity

A Current Ratio of 3.62 indicates that ENFN has no problem at all paying its short term obligations.
ENFN has a Current ratio of 3.62. This is in the better half of the industry: ENFN outperforms 79.93% of its industry peers.
ENFN has a Quick Ratio of 3.62. This indicates that ENFN is financially healthy and has no problem in meeting its short term obligations.
ENFN has a better Quick ratio (3.62) than 80.29% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.62

8

3. Growth

3.1 Past

ENFN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.86%, which is quite impressive.
The Revenue has grown by 15.77% in the past year. This is quite good.
Measured over the past years, ENFN shows a very strong growth in Revenue. The Revenue has been growing by 29.91% on average per year.
EPS 1Y (TTM)42.86%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)15.77%
Revenue growth 3Y29.91%
Revenue growth 5YN/A
Sales Q2Q%15.24%

3.2 Future

Based on estimates for the next years, ENFN will show a very strong growth in Earnings Per Share. The EPS will grow by 40.06% on average per year.
The Revenue is expected to grow by 17.54% on average over the next years. This is quite good.
EPS Next Y54.82%
EPS Next 2Y45.36%
EPS Next 3Y40.06%
EPS Next 5YN/A
Revenue Next Year17.22%
Revenue Next 2Y17.48%
Revenue Next 3Y17.54%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 52.90, which means the current valuation is very expensive for ENFN.
Compared to the rest of the industry, the Price/Earnings ratio of ENFN is on the same level as its industry peers.
ENFN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.54.
The Price/Forward Earnings ratio is 35.77, which means the current valuation is very expensive for ENFN.
Based on the Price/Forward Earnings ratio, ENFN is valued a bit cheaper than the industry average as 63.80% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ENFN to the average of the S&P500 Index (23.99), we can say ENFN is valued slightly more expensively.
Industry RankSector Rank
PE 52.9
Fwd PE 35.77

4.2 Price Multiples

64.16% of the companies in the same industry are more expensive than ENFN, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ENFN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 64.55
EV/EBITDA 70.05

4.3 Compensation for Growth

ENFN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ENFN's earnings are expected to grow with 40.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y45.36%
EPS Next 3Y40.06%

0

5. Dividend

5.1 Amount

ENFN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENFUSION INC - CLASS A

NYSE:ENFN (12/24/2024, 8:08:27 PM)

After market: 10.58 0 (0%)

10.58

+0.06 (+0.57%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners95.46%
Inst Owner Change-0.43%
Ins Owners5.25%
Ins Owner Change-0.49%
Market Cap1.36B
Analysts55.71
Price Target10.05 (-5.01%)
Short Float %0.95%
Short Ratio1.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.96%
Min EPS beat(2)-12.85%
Max EPS beat(2)0.93%
EPS beat(4)2
Avg EPS beat(4)6.26%
Min EPS beat(4)-25.3%
Max EPS beat(4)62.27%
EPS beat(8)3
Avg EPS beat(8)1.26%
EPS beat(12)5
Avg EPS beat(12)1.23%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.01%
Min Revenue beat(2)-3.12%
Max Revenue beat(2)-2.9%
Revenue beat(4)1
Avg Revenue beat(4)-1.77%
Min Revenue beat(4)-3.12%
Max Revenue beat(4)0.02%
Revenue beat(8)1
Avg Revenue beat(8)-2.29%
Revenue beat(12)4
Avg Revenue beat(12)-1.17%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.82%
PT rev (3m)6.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE 52.9
Fwd PE 35.77
P/S 6.97
P/FCF 64.55
P/OCF 43.06
P/B 19.45
P/tB 19.45
EV/EBITDA 70.05
EPS(TTM)0.2
EY1.89%
EPS(NY)0.3
Fwd EY2.8%
FCF(TTM)0.16
FCFY1.55%
OCF(TTM)0.25
OCFY2.32%
SpS1.52
BVpS0.54
TBVpS0.54
PEG (NY)0.96
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.48%
ROE 4.78%
ROCE 6.02%
ROIC 4.85%
ROICexc 8.57%
ROICexgc 8.57%
OM 3.44%
PM (TTM) 1.71%
GM 67.16%
FCFM 10.8%
ROA(3y)-59.38%
ROA(5y)-22.58%
ROE(3y)-113.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-18.81%
ROICexcg growth 5YN/A
ROICexc growth 3Y-18.81%
ROICexc growth 5YN/A
OM growth 3Y-3.69%
OM growth 5YN/A
PM growth 3Y-11.03%
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5YN/A
F-Score4
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 87.49%
Cap/Sales 5.39%
Interest Coverage 250
Cash Conversion 168.69%
Profit Quality 630.93%
Current Ratio 3.62
Quick Ratio 3.62
Altman-Z 12.95
F-Score4
WACC11.83%
ROIC/WACC0.41
Cap/Depr(3y)141.06%
Cap/Depr(5y)205.29%
Cap/Sales(3y)6%
Cap/Sales(5y)6.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.86%
EPS 3Y0%
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y54.82%
EPS Next 2Y45.36%
EPS Next 3Y40.06%
EPS Next 5YN/A
Revenue 1Y (TTM)15.77%
Revenue growth 3Y29.91%
Revenue growth 5YN/A
Sales Q2Q%15.24%
Revenue Next Year17.22%
Revenue Next 2Y17.48%
Revenue Next 3Y17.54%
Revenue Next 5YN/A
EBIT growth 1Y-40.08%
EBIT growth 3Y25.12%
EBIT growth 5YN/A
EBIT Next Year102.55%
EBIT Next 3Y51.21%
EBIT Next 5YN/A
FCF growth 1Y401.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3706.39%
OCF growth 3Y148.52%
OCF growth 5YN/A